enGene Holdings Inc.
ENGN • NASDAQ
enGene Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ronald H. W. Cooper, with a market cap of $426.7M.
CEORonald H. W. Cooper
Next Earnings
Upcoming earnings announcement for enGene Holdings Inc.
Date
Thursday, June 11, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.48
Earnings History
Past 10 earnings reports for enGene Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q1 2026 | -$0.44Est: -$0.56 | +21.4% | - | — |  10-Q |
| Dec 22, 2025 | Q4 2025 | -$0.73Est: -$0.57 | -28.1% | - | — | 10-K/A |
| Sep 11, 2025 | Q3 2025 | -$0.57Est: -$0.50 | -14.0% | - | — | 10-Q |
| Jun 12, 2025 | Q2 2025 | -$0.51Est: -$0.40 | -27.5% | — | — | 10-Q |
| Mar 10, 2025 | Q1 2025 | -$0.48Est: -$0.38 | -26.3% | - | — | 10-Q |
| Dec 19, 2024 | Q4 2024 | -$0.34Est: -$0.41 | +17.1% | - | — | 10-K |
| Sep 10, 2024 | Q3 2024 | -$0.32Est: -$0.37 | +13.5% | - | — | 10-Q |
| Jun 14, 2024 | Q2 2024 | -$0.38Est: -$0.29 | -31.0% | - | — | 10-Q |
| Mar 11, 2024 | Q1 2024 | -$0.46 | — | - | — | 10-Q |
| Jan 29, 2024 | FY 2023 | -$151.22 | — | - | — | — |